Medical treatment of metastatic melanoma

Surgical Clinics of North America

Volumn 76, Issue 6, 1996, Pages 1343-1354

  Houghton, A N ^a   Meyers, M L ^a   Chapman, P B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMIFOSTINE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYTOKINE; DACARBAZINE; DOCETAXEL; FOTEMUSTINE; HYDROXYUREA; INTERLEUKIN 2; LOMUSTINE; MELATONIN; MELPHALAN; NITROSOUREA DERIVATIVE; PACLITAXEL; PIRITREXIM; SEMUSTINE; VINBLASTINE; VINCRISTINE; VINDESINE;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG MEGADOSE; GASTROINTESTINAL TOXICITY; HUMAN; INJECTION PAIN; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA;

EID: 0030466372     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70519-3     Document Type: Article

References (113)

1. D.L. Ahmann R.G. Hahn H.F. Bisel A comparative study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037) and imidazole carboxamide (NSC-45388) with vincristine (NSC-67574) in the palliation of disseminated malignant melanoma Cancer Res 32 1972 2432 2440
2. D.L. Ahmann R.G. Hahn H.F. Bisel Evaluation of 1-(2-chloroethyl-3-4-methyl-cyclohexyl)-1-nitrosourea (methyl-CCNU, NSC-95441) versus combined imidazole carboxamide (NSC-45388) and vincristine (NSC-67574) in palliation of disseminated melanoma Cancer 33 1974 615
3. M. Al-Sarraf W. Fletcher N. Oishi Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: Southwest Oncology Group study Cancer Treat Rep 66 1982 31 39
4. K. Antman J.P. Eder Elias High dose combination alkylating agent preparative regimen with autologous bone marrow support: The Dana-Farber Cancer Institute/Beth Israel Hospital experience Cancer Treat Rep 71 1987 119 125
5. M. Atkins K. O'Boyle J. Sosman Multi-institutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanoma J Clin Oncol 12 1994 1553 1560
6. A. Bedikian G. Weiss S. Legha Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy J Clin Oncol 13 1995 2895 2899
7. E. Bejetta A. Di Leo M. Zampino Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon-α 2a in the treatment of melanoma J Clin Oncol 12 1994 806 811
8. A. Buzaid S. Legha R. Winn Cisplatin, vinblastine, and dacarbazine versus dacarbazine alone in metastatic melanoma: Preliminary results of a phase III Cancer Community Oncology Program (CCOP) trial Proc Am Soc Clin Oncol 12 1993 389
9. A. Buzaid J. Murren H. Durivage High-dose cisplatin with dacarbazine and tamoxifen in the treatment of metastatic melanoma Cancer 68 1991 1238 1241
10. J. Carmichael R.J. Atkinson K.C. Calman A multicentre phase II trial of vindesine in malignant melanoma J Cancer Clin Oncol 18 1982 1293 1295
11. P. Chang W.H. Knapper Metastatic melanoma of unknown primary Cancer 49 1982 1106 1112
12. G. Cocconi M. Bella F. Calabresi Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen N Engl J Med 327 1992 516 523
13. R.L. Comis DTIC (NSC-45388) in malignant melanoma: A perspective Cancer Treat Rep 64 1976 1123 1138
14. M.E. Costanza L. Nathanson D. Schoenfeld Results with methyl-CCNU and DTIC in metastatic melanoma Cancer 40 1977 1010 1018
15. J.J. Costanzi M. Al-Sarraf C. Groope Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A Southwest Oncology Group study Med Pediatr Oncol 10 1982 251 255
16. J.J. Costanzi M. Al-Sarraf C. Groppe Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma. A Southwest Oncology Group study Med Pediatr Oncol 53 1982 833 841
17. J.J. Costanzi W.S. Fletcher S.P. Balcerzak Combination chemotherapy plus levamisole in the treatment of disseminated malignant melanoma: A Southwest Oncology Group study Cancer 53 1984 833 836
18. J.J. Costanzi V.K. Vaitkevicius J.M. Quagliana Combination chemotherapy for disseminated malignant melanoma Cancer 35 1975 342 346
19. E.T. Creagan J.N. Ingle D.L. Ahmann Phase II study of high-dose tamoxifen (NSC-1809073) in patients with disseminated melanoma Cancer 49 1982 1353 1358
20. S.A. DelPrete L.H. Maurer J. O'Donnell Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma Cancer Treat Rep 68 1984 1403 1405
21. P. Demchak J. Mier N. Robert Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: A pilot study J Clin Oncol 9 1991 1821 1830
22. V.T. DeVita P.P. Carbone A.H. Owens Jr Clinical trials with 1, 3-bis (2-chloroethyl)-1-nitrosourea, NSC-409962 Cancer Res 25 1965 1875 1882
23. G. DeWasch J. Bernheim J. Michel Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin in the treatment of stage III melanoma Cancer Treat Rep 60 1976 1273 1276
24. M. Dhodapkar J. Reid M. Ames Phase I clinical trial and pharmacokinetics of temozolamide (NSC 362856) [abstract] Proc Am Assoc Cancer Res 35 1994 245
25. N.J. DiBella R. Berris D. Garfield Vindesine in advanced breast cancer, lymphoma and melanoma Invest New Drugs 2 1984 323 328
26. R. Dillman R. Oldham N. Barth Recombinant interleukin-2 and adoptive immunotherapy alternated with dacarbazine therapy in melanoma: A National Biotherapy Study Group trial J Natl Cancer Inst 82 1990 1345 1349
27. R. Dummer M. Gore B. Hancock A multicenter phase II clinical trial using dacarbazine and continuous infusion interleukin-2 for metastatic melanoma Cancer 75 1995 1038 1044
28. A. Einig H. Hochester P. Wiernik A phase II study of taxol in patients with malignant melanoma Invest New Drugs 9 1991 59 64
29. A. Einzig L. Schuchter S. Wadler Phase II trial of taxotere (RP 56976) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy Proc Am Soc Clin Oncol 13 1994 395
30. L. Evans E.S. Casper R. Rosenbluth Phase II trial of carboplatin in advanced malignant melanoma Cancer Treat Rep 71 1987 171 174
31. C. Falkson G. Falkson H. Falkson Improved results with the addition of interferon alpha 2a to dacarbazine in the treatment of patients with metastatic malignant melanoma J Clin Oncol 9 1991 1403 1408
32. C. Falkson J. Ibrahim J. Kirkwood A randomized phase III trial of dacarbazine (DTIC) versus DTIC + interferon alpha-2b (IFN) versus DTIC + tamoxifen (TMX) versus DTIC+IFN+TMX in metastatic malignant melanoma [abstr] Proc Am Soc Clin Oncol 15 1996 435
33. G. Falkson J.J. Van Dyk H.F. Verwoerd The chemotherapy of malignant melanoma S Afr Med J 42 1968 89 90
34. W. Ferri S. Argarwala J. Kirkwood Carboplatin and dacarbazine +/− tamoxifen for metastatic melanoma Proc Am Soc Clin Oncol 13 1994 394
35. L. Feun R. Gonzalez N. Savaraj Phase II trial of piritrexim in metastatic melanoma using intermittent low-dose administration J Clin Oncol 9 1991 464 467
36. L. Feun N. Savaraj F. Moffat Combination of BCNU, DTIC, cisplatin, and tamoxifen with alpha-interferon in stage IV melanoma 38th Annual Clinical Conference of Advances in the Biology and Clinical Management of Melanoma, Houston 1995 101
37. W. Fiedler C. Jasmin De Mulder P. A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma Eur J Cancer 28 1992 443 446
38. L. Flaherty P. Liu D. Daniels The addition of tamoxifen to dacarbazine and cisplatin in a SWOG phase II trial in metastatic malignant melanoma stage IV Proc Am Soc Clin Oncol 12 1993 394
39. L. Flaherty P. Liu W. Fletcher Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: A phase II Southwest Oncology Group trial J Natl Cancer Inst 84 1992 893 894
40. L. Flaherty W. Robinson B. Redman A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic melanoma Cancer 71 1993 3520 3525
41. W.S. Fletcher S. Green J.R. Feltcher Evaluation of cis -platinum and DTIC combination chemotherapy in disseminated melanoma Am J Clin Oncol 11 1988 589 593
42. E. Franco PFMSG Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). The Prudente Foundation Melanoma Study Group Cancer 63 1989 1676 1680
43. D. Glover J.H. Glick C. Weiler WR2721 and high-dose cisplatin: An active combination in the treatment of metastatic melanoma J Clin Oncol 5 1987 574 578
44. D. Glover S. Grabelsky K. Fox Clinical trials of WR-2721 and cis -platinum Int J Rad Oncol Biol Phys 16 1989 1201 1204
45. R. Gonzales A. Sanchez J. Ferguson Melatonin therapy of advanced human malignant melanoma Melanoma Res 1 1991 237 243
46. J.E. Goodnight Jr H.S. Moseley F.R. Eilber cis -Dichlorodiammineplatinum (II) alone and combined with DTIC for treatment of disseminated malignant melanoma Cancer Treat Rep 63 1979 2005 2009
47. S. Gundersen Dacarbazine, vindesine and cisplatin combination chemotherapy in advanced malignant melanoma: A phase II study Cancer Treat Rep 71 1987 997 999
48. A.A. Hakim Correlation between tyrosine hydroxylase activity, melanogenesis, and estradiol binding in human melanoma cells Res Exp Med (Berl) 180 1982 99 102
49. G.J. Hill Jr E.T. Krementz H.Z. Hill Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma: IV. Late results after complete response to chemotherapy Cancer 53 1984 1299 1310
50. M.E. Hodes R.J. Rohn W.H. Bond Vincaleukoblastine. IV: A summary of two and a one-half years' experience in the use of vinblastine Cancer Chemother Rep 16 1962 401 406
51. B. Hoogstraten J.A. Gottlieb E. Caoili CCNU (1-(2m cgkirietgtk)-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer Cancer 32 1973 38 42
52. D. Khayat M. Avril G. Auclerc Clinical value of the nitrosourea fotemustine in disseminated malignant melanoma: Overview on 1022 patients including 144 patients with cerebral metastases Proc Am Soc Clin Oncol 12 1993 393
53. D. Khayat Bizzari J.-P. M. Frenay Interim report of phase II study of new nitrosourea S 10036 in disseminated malignant melanoma J Natl Cancer Inst 80 1988 1407 1408
54. D. Khayat F. Lokiec Bizzari J.-P. Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule Cancer Res 47 1987 6782 6785
55. J. Kirkwood M. Ernstoff A. Giuliano Interferon alpha 2a and dacarbazine in melanoma J Natl Cancer Inst 82 1990 1062 1063
56. U. Kleeberg E. Engel E. Bröcker Effect of toremifene in patients with metastatic melanoma: A phase II study of the EORTC melanoma cooperative group Melanoma Res 3 1993 123 126
57. H.M. Lazarus R.H. Herzig J. Graham-Pole Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer J Clin Oncol 1 1983 359 368
58. S. Legha Current therapy in malignant melanoma Semin Oncol 16 1989 34 44
59. S. Legha A. Buzaid S. Ring Improved results of treatment of metastatic melanoma with combined use of biotherapy and chemotherapy Proc Am Soc Clin Oncol 13 1994 394
60. S. Legha S. Ring A. Bedikian Lack of benefit from tamoxifen added to regimen of cisplatin (C), vinblastine (V), DTIC (D) and alpha interferon (IFN) in patients with metastatic melanoma Proc Am Soc Clin Oncol 12 1993 388
61. S. Legha S. Ring N. Papadopoulos A phase II trial of taxol in metastatic melanoma Cancer 65 1990 2478 2481
62. S.S. Legha S. Ring N. Papadopoulos A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma Cancer 64 1989 2024 2029
63. C.G. Leichman M.K. Samson L.H. Baker Phase II trial of tamoxifen in malignant melanoma, Cancer Treat Rep 66 1982 1447 1448
64. J.K. Luce Chemotherapy of malignant melanoma Cancer 30 1972 1604 1615
65. J.K. Luce W.G. Thurman B.L. Isaacs Clinical trials with the antitumor agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) Cancer Chemother Rep 54 1970 119 124
66. S.D. Luikart G.T. Kennealey J.M. Kirkwood Randomized phase III trial of vinblastine, bleomycin and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma J Clin Oncol 2 1984 164 170
67. K. Margolin J. Doroshow S. Akman Treatment of advanced melanoma with cis -diammine-dichloro-platinum (CDDP) and alpha interferon (aIFN) Proc Am Soc Clin Oncol 9 1990 277
68. S. Marsoni D. Hoth R. Simon Clinical drug development. An analysis of phase II trials, 1970–1985 Cancer Treat Rep 71 1987 71 79
69. G. Mavligit C. Carrasco N. Papadopoulos Regression of ocular melanoma metastatic to the liver after chemoembolization with cis -platinum and polyvinyl sponge Proc Am Soc Clin Oncol 6 1987 830
70. E.F. McClay M.J. Mastrangelo R.E. Bellet Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma Cancer Treat Rep 71 1987 465 469
71. E.F. McClay M.J. Mastrangelo J.D. Sprandio The importance of tamoxifen to a cisplatin-containing regimen in the treatment of metastatic melanoma Cancer 63 1989 1292 1295
72. R. Morton E. Creagan D. Schaid Phase II trial of recombinant leukocyte A interferon (IFN-alpha-2a) plus 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patients with disseminated malignant melanoma Am J Clin Oncol (CCT) 14 1991 152 155
73. J.H. Mulder P. Dodion F. Cavalli Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: An EORTC Phase II study Eur J Cancer Clin Oncol 18 1982 1297 1301
74. L. Nathanson S.D. Kaufman R.W. Carey Vinblastine infusion, bleomycin and cis -dischlorodiammine-platinum chemotherapy in metastatic melanoma Cancer 48 1981 1290 1294
75. L. Nathanson J. Wolter J. Horton Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma Clin Pharmacol Ther 12 1971 955 962
76. National Cancer Institute of Canada Melanoma Group Vinblastine, bleomycin and cis -platinum for the treatment of metastatic malignant melanoma J Clin Oncol 2 1984 131 137
77. N. Papadopoulos J. Howard J. Murray Phase II DTIC and interleukin-2 (IL-2) trial for metastatic malignant melanoma Proc Am Soc Clin Oncol 9 1990 277
78. G.L. Phillips J.W. Fay G.P. Herzig Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). NSC-409962 and cryopreserved autologous marrow transplantation for refractory cancer: A phase I–II study Cancer 52 1983 1792 1802
79. G.L. Phillips J.W. Fay G.P. Herzig Intensive 1, 3-bis(2-chloroethyl-1-nitrosourea (BCNU) with autologous bone marrow transplantation therapy of refractory cancer: A preliminary report Exp Hematol 7 1979 372 381
80. K.I. Pritchard I.C. Quirt D.H. Cowan DTIC therapy in metastatic malignant melanoma: A simplified dose schedule Cancer Treat Rep 64 1980 1123 1126
81. S. Pyrhonen M. Hahka-Kemppinen T. Muhonen A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma J Clin Oncol 10 1992 1919 1926
82. J.M. Quagliana R.L. Stephens L.H. Baker Vindesine in patients with metastatic malignant melanoma: A Southwest Oncology Group study J Clin Oncol 2 1984 316 319
83. G. Ramirez W. Wilson T. Grage Phase II evaluation of 1,3-bis(e chlorethyl-neurosourea) (BCNU; NSC-409962) in patients with solid tumors Cancer Chemother Rep 56 1972 787 793
84. S. Retsas A. Athanasiou M.D. Flynn Combination chemotherapy with vindesine and DTIC in advanced malignant melanoma Proc Am Soc Clinic Oncol 1 1982 169a
85. S. Retsas I. Peat R. Ashford Updated results of vindesine as a single agent in the therapy of advanced malignant melanoma Cancer Treat Rev 7 1980 87 90
86. J. Richards N. Mehta K. Ramming Sequential chemoimmunotherapy in the treatment of metastatic melanoma J Clin Oncol 10 1992 1338 1343
87. U. Ringborg U. Jungnelius J. Hansson DTIC-vindestine-cisplatin in disseminated malignant melanoma: A phase II study Proc Am Soc Clin Oncol 6 1987 212
88. O. Rixe A. Benhammouda E. Antoine Final results of a prospective multicentric study on 91 metastatic malignant melanoma patients treated by chemo-immunotherapy with cisplatin, interleukin-2, and interferon-alpha Proc Am Soc Clin Oncol 13 1994 399
89. C. Rose L. Pederson H.T. Mouridsen Endocrine treatment with antiestrogen, anti-androgen or progestagen of advanced malignant melanoma: Three consecutive phase II trials Eur J Cancer Clin Oncol 21 1985 1171 1174
90. P. Rümke U. Kleeberg R. MacKie Tamoxifen as a single agent for advanced melanoma in postmenopausal women: A phase II study of the EORTC malignant melanoma cooperative group Melanoma Res 2 1992 153 156
91. J. Rusthoven I. Quirt N. Iscoe A randomized placebo-controlled trial comparing BCNU (B), dacarbazine (D), and cisplatin (P) vs BDP and high-dose tamoxifen in the treatment of metastatic melanoma Proc Am Soc Clin Oncol 14 1995 413
92. M Schultz, A Buzaid, W Poo. A phase II study of interferon-α 2b with dacarbazine, cisplatin, carmustine, and tamoxifen in metastatic melanoma Melanoma Res, in press
93. H.F. Seigler V.S. Lucas Jr N.J. Pickett DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma Cancer 46 1980 2346 2348
94. K. Smith J. Green J. Eccles Interferon alpha 2a and vindesine in the treatment of advanced malignant melanoma Eur J Cancer 28 1992 438 441
95. G. Spitzer K. Dicke A.R. Zander High-dose chemotherapy with autologous bone marrow transplantation Cancer 54 1984 216 224
96. J. Stark R. Schulof M. Wiemann Alpha interferon and chemo-hormonal therapy in advanced melanoma: A phase I/II NBSG/MAOP study Proc Am Soc Clin Oncol 12 1993 392
97. T.A. Steffens D.F. Bajorin P.B. Chapman A phase II trial of high-dose cisplatin and dacarbazine: Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma Cancer 68 1991 1230 1237
98. G. Stoter S. Aamdal S. Rodenhuis Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: A multicenter phase II study J Clin Oncol 9 1991 1687 1691
99. N.S. Tchekmedyican N. Tait van Echo D. High-dose chemotherapy without autologous bone marrow transplantation in melanoma J Clin Oncol 4 1986 1811 1820
100. R. Telhaug O. Klepp O. Bremer Phase II study of tamoxifen in patients with metastatic malignant melanoma Cancer Treat Rep 66 1982 1437 1438
101. M.R. Thomas W.A. Robinson L.M. Glode Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation: Preliminary results: Phase I study Am J Clin Oncol 5 1982 611 620
102. D. Thomson M. Adena G. McLeod Interferon-α 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: Results of a multi-institutional Australian randomized trial Melanoma Res 3 1993 133 138
103. L.B. Tyson R.A. Clark R.J. Gralla High-dose metoclopramide: Control of dacarbazine-indused emesis in a preliminary trial Cancer Treat Rep 66 1982 2108 2109
104. van der Hoop R.G. C.J. Vecht van der Burg Me Prevention of cisplatin neurotoxicity with an ACTH (4-9) analogue in patients with ovarian cancer N Engl J Med 322 1994 89 94
105. M. Vouristo P. Gröhn P. Kellokumpu-Lehtinen Intermittent interferon and polychemotherapy in metastatic melanoma J Cancer Res Clinic Oncol 121 1995 175 180
106. D.E. Wagner G. Ramirez A.J. Weiss Combination phase I–II study of imidazole carboximide (NSC 45388) Oncology 26 1971 310 316
107. J. Wagstaff N. Thatcher E. Rankin Tamoxifen in the treatment of metastatic melanoma Cancer Treat Rep 66 1982 1171 1172
108. T.H. Wasserman M. Slavik S.K. Carter Methyl-CCNU in clinical cancer therapy Cancer Treat Rev 1 1974 252 266
109. T.H. Wasserman M. Slavik S.K. Carter Review of CCNU in clinical cancer therapy Cancer Treat Rev 1 1974 131 144
110. P.H. Wiernik E.L. Schwartz A. Einzig Phase II trial of taxol given as a 24-hour infusion every 2 days: Responses observed in metastatic melanoma J Clin Oncol 5 1987 1232 1239
111. R.E. Wittes J.T. Wittes R.B. Golbey Combination chemotherapy in metastatic malignant melanoma: A randomized study of three DTIC-containing combinations Cancer 41 1978 415 420
112. R. York A. Foltz Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma Cancer 61 1988 2183 2186
113. R.C. Young G.P. Canellos B.A. Chabner Treatment of malignant melanoma with methyl-CCNU Cancer Pharmacol Ther 15 1974 617 622